The Journal of Practical Medicine ›› 2022, Vol. 38 ›› Issue (20): 2549-2555.doi: 10.3969/j.issn.1006⁃5725.2022.20.008

• Clinical Research • Previous Articles     Next Articles

Impact of intravenous anesthesia vs. inhalation anesthesia on perioperative T cells subsets in patients with colorectal cancer

 LI FuyuFENG JianguoWANG XiaobinBAI Yiping.   

  1. Department of AnesthesiologyAffiliated Hospital of Southwest Medical UniversityLuzhou 646000China 

  • Online:2022-10-25 Published:2022-10-25
  • Contact: BAI Yiping E⁃mail:baiyiping0608@163.com
  • Supported by:


Abstract:

Objective To compare the impact of intravenous anesthesia versus inhalation anesthesia on T cell subsets and CD8+ T cell surface signaling molecules in patients with colorectal cancer. Methods Sixty⁃four patients with colorectal cancer undergoing elective radical resection were randomly divided into Sev groupn = 32and Pro groupn = 32. The Sev group was treated with inhalation of sevofluraneand the Pro group received intra⁃ venous infusion of propofol. Peripheral blood samples were collected before anesthesiaT1),2 hours after anesthesia T2),3 days after operationT3and 7 days after operationT4. CD4+ TCD8+ TCD28+ CD8+ TPD⁃1+ CD8+ TCD45RO+ CD62LCD8+ T and CD45RO+ CD62L+ CD8+ T were detected and analyzed. Results CD4+ T/CD8+ T at T2 was lower than that at T1 in both groups. CD4+ TCD4+ T/CD8+ T in the Sev group were lower than thatin the Pro Group at T2 and T3PD⁃1+ CD8+ T was higher than that in the Pro Group at T2and CD28+ CD8+ T was lower than that in the Pro Group at T2P < 0.05. CD45RO+ CD62LCD8+ T and CD45RO+ CD62L+ CD8+ T in the Sev group were lower than those in the Pro group at T3 and T4P < 0.05. Conclusion General anesthesia may cause immunosuppression in colorectal cancer patients and the intravenous anesthesia of propofol causes less immunosuppression. Moreover intravenous anesthesia of propofolhas less inhibitory effect on memory T cellsas compared to inhalation anesthesia of sevoflurane. 

Key words: general anesthesia,  , colorectal cancer,  , T cell,  , CD4,  , CD8